XML 57 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Asset - Nucynta Acquisitions (Details) - Nucynta Purchase Agreement - Nucynta Products
$ in Thousands
 1 Months Ended
Feb. 29, 2020
USD ($)
Acquisition consideration:  
Base purchase price $ 375,000
Cash paid for inventory 6,030
Transaction costs 6,297
Reduction for 2020 cash transferred to Assertio under the prior Nucynta Commercialization Agreement (13,071)
Reduction for accrued royalty obligation discharged upon closing (1,145)
Total acquisition consideration 373,111
Reduction to base purchase price 14,216
Consideration transferred to assets acquired:  
Nucynta Intangible Asset 367,081
Inventory 6,030
Total consideration allocated to assets acquired 373,111
Assertio  
Finite-Lived Intangible Assets [Line Items]  
Aggregate purchase price $ 375,000